|Articles|June 20, 2023

Ongoing Infectious Disease Studies Update - June 20, 2023

Latest number of infectious disease clinical trials from ClinicalTrials.gov.

As of June 20, 2023, there are 911 infectious disease studies in Phases I-III that are recruiting, not yet recruiting, or in the interventional stage according to ClinicalTrials.gov. A breakdown by region via a global map can be found below.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Ongoing Infectious Disease Studies Update - June 20, 2023

Newsletter

Related Content

Reducing Site Burden Through Better Technology Integration in Clinical Trials

Broad Survival Benefit from MATTERHORN Trial Highlights New Approach to Biomarker Use

Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer

ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen

Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials

Trending on Applied Clinical Trials Online

Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer

Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development

Reducing Site Burden Through Better Technology Integration in Clinical Trials

ACT Brief: AI Partnerships, Data-Driven Site Activation, and FDA Approval for Omvoh’s Single-Injection Regimen

Broad Survival Benefit from MATTERHORN Trial Highlights New Approach to Biomarker Use